Initiation of nonselective alpha1-antagonist therapy and occurrence of hypotension-related adverse events among men with benign prostatic hyperplasia: a retrospective cohort study
- 1 May 2001
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 23 (5) , 727-743
- https://doi.org/10.1016/s0149-2918(01)80022-9
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- A Meta-Analysis on the Efficacy and Tolerability of α1-Adrenoceptor Antagonists in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic ObstructionEuropean Urology, 1999
- Terazosin in benign prostatic hyperplasia: effects on blood pressure in normotensive and hypertensive menBritish Journal of Urology, 1998
- Long-Term Evaluation of Tamsulosin in Benign Prostatic Hyperplasia: Placebo-Controlled, Double-Blind Extension of Phase III TrialUrology, 1998
- Phase III Multicenter Placebo-Controlled Study of Tamsulosin in Benign Prostatic HyperplasiaUrology, 1998
- Pharmacotherapy for benign prostatic hyperplasia — the potential for α1‐adrenoceptor subtype‐specific blockadePublished by Wiley ,1998
- The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic HyperplasiaNew England Journal of Medicine, 1998
- Doxazosin for Benign Prostatic Hyperplasia: Long-term Efficacy and Safety in Hypertensive and Normotensive PatientsJournal of Urology, 1997
- Long-term efficacy and safety of terazosin in patients with benign prostatic hyperplasiaUrology, 1995
- Natural history of benign prostatichyperplasia and risk of prostatectomy: The Baltimore Longitudinal Study of AgingUrology, 1991
- The Development of Human Benign Prostatic Hyperplasia with AgeJournal of Urology, 1984